All you need to know about Mucormycosis

21/06/2021

Mucormycosis is a rare fungal infection that has been on the rise in India. It can be caused by exposure to certain types of mold and spores. The fungus spreads through the body, destroying healthy tissue and organs. There is an unusual rise in Mucormycosis cases among Covid-19 patients. A recent study found that the second wave of Mucormycosis cases are those who have recovered from the first wave of Covid-19 but still have uncontrolled diabetes or were treated with steroids. This means that these people are more likely to be infected by mucormycosis during their recovery period rather than being at risk for it before they even contracted COVID as well as after recovery from the virus itself.

Watch Dr Prashanth Reddy, Chief ENT and endoscopic skull base surgeon at BGS Gleneagles Global Hospital as he talks about all the things you need to know about Mucormycosis.

What is Mucormycosis?

What are the initial symptoms of Mucormycosis?

How do we diagnose Mucormycosis?

Why is there a sudden rise in Mucormycosis cases in the second wave?

What is the treatment of Mucormycosis?

Why is there an anti-fungal shortage?

Latest Blogs

Whiplash
Heartburn

Popular Blogs

Department of Renal Sciences at BGS Gleneagles Global Hospital, Kengeri
All you need to know about Mucormycosis
Comparison of COVID-19 Vaccines in India: Covishield V/s Covaxin